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Chemokines and their receptors play a crucial part in
the recruitment of leukocytes into inflammatory sites.
The CXC chemokines IP-10 and Mig are selective
attractants for activated (memory) T cells, the predom-
inant cell type in skin infiltrates in many inflammatory
dermatoses. The selectivity for activated T cells can
be explained by the fact that both chemokines exert
their effects through a common receptor, CXCR3,
which is nearly exclusively expressed on activated
T cells. The aim of this study was to identify biologic-
ally active CXCR3 ligands produced by keratinocytes.
To that end, Chinese hamster ovary cells expressing a
cDNA encoding CXCR3 were challenged with
proteins obtained from interferon-g stimulated ker-
atinocytes and subsequently monitored for effects on
second messenger systems. By this approach we were
able to isolate IP-10 and Mig, and in addition identified
a novel highly potent ligand for the CXCR3 receptor,
Inflammatory skin diseases are characterized by the presenceof leukocyte infiltrates in the dermis and epidermis, mainlyconsisting of activated T cells. Keratinocytes are thought tobe directly involved in the genesis of these infiltrates byproducing chemokines, now known to be not only active
as chemotactic factors but also as end-point regulators of immune
effector functions. Chemokines are small heparin-binding proteins
that are classified into CXC, CC, C, and CXXXC subfamilies,
based on the position of characteristic structure determining cysteine
residues within the N-terminal part of the proteins (Baggiolini et al,
1997; Luster, 1998).
The interferon (IFN)-γ-induced chemokines IP-10 (interferon-
γ-inducible protein-10) and Mig are members of the CXC family
recruiting activated T cells by mobilization of intracellular Ca21
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designated interferon-g-inducible protein-9, which
proved to be chemotactic for activated T cells
expressing CXCR3. Protein sequence and mass spec-
trometric analysis followed by molecular cloning of
the cDNA encoding interferon-g-inducible protein-9,
revealed that interferon-g-inducible protein-9 is a CXC
chemokine with a molecular mass of 8303 Da. From
a GenBank database query it became clear that inter-
feron-g-inducible protein-9 is in fact the protein
encoded by the cDNA sequence also known as b-R1,
H174 or I-TAC. In situ hybridization experiments
showed that interferon-g-inducible protein-9 mRNA
is expressed by basal layer keratinocytes in a variety
of skin disorders, including allergic contact dermatitis,
lichen planus, and mycosis fungoides suggesting a
functional role for this chemokine in skin immune
responses. Key words: H174/high-performance liquid chro-
matography/in situ hybridization/I-TAC/b-R1. J Invest
Dermatol 112:716–722, 1999
and induction of chemotaxis (Luster et al, 1985; Liao et al, 1995;
Farber, 1997). The selectivity for activated T cells, shared by these
chemokines, can be explained by the fact that both chemokines
exert their effects through at least one common G protein-coupled,
seven transmembrane domain receptor designated CXCR3, which
is nearly exclusively expressed on activated T cells (Loetscher et al,
1996; Qin et al, 1998; Sallusto et al, 1998). Thus, keratinocyte
derived IP-10 and Mig are likely to contribute to preferential
accumulation of activated T cells into the skin. Using immunologic
detection methods or mRNA in situ hybridization techniques
IP-10 has indeed been found in delayed-type hypersensitivity
reactions (Kaplan et al, 1987), psoriatic plaques (Gottlieb et al,
1988), and cutaneous T cell lymphoma (Sarris et al, 1995; Tensen
et al, 1998a). Recently we demonstrated Mig mRNA expression
in epidermotropic cutaneous T cell lymphoma (Tensen et al, 1998a).
The aim of this study was to identify biologically active chemok-
ines produced by keratinocytes, which might be involved in the
attraction of activated T cells during skin inflammation. For that
purpose, we applied a strategy previously shown to be successful
for the identification of biologic active ligands for (orphan) receptors
(Cox et al, 1997; Tensen et al, 1998b, c). We expressed a CXCR3
encoding cDNA in Chinese hamster ovary (CHO) cells, which
were subsequently challenged with purified proteins obtained from
supernatants of stimulated keratinocytes. Active fractions, selected
on the basis of their ability to activate CXCR3 by mobilizing
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Ca21 in the transfected CHO cells, were analyzed by amino acid
sequence analysis. With this approach we were able to isolate
biologically active IP-10 and Mig. In addition, we identified
another IFN-γ induced CXC chemokine, tentatively designated
IP-9 (IFN-γ-inducible protein-9). We undertook biochemical
(N-terminal sequence analysis), biophysical (mass determination),
and functional characterization (activity towards CXCR3) of the
chemokine protein. As sequence analysis revealed homology to an
incomplete GenBank entry (designated β-R1; Rani et al, 1996),
we used polymerase chain reaction (PCR) to generate a correct
cDNA encoding IP-9, also permitting detection of IP-9 mRNA
expression by in situ hybridization in the epidermis of several
inflammatory dermatoses (allergic contact dermatitis, lichen planus,
and mycosis fungoides). After submission of the sequence data to
GenBank and when this manuscript was under review, it became
clear that IP-9 is in fact the protein also encoded by the cDNA
sequences known as, H174 (Jacobs et al, 1997) and I-TAC
(Cole et al, 1998).
MATERIALS AND METHODS
Cell culture Keratinocytes were obtained from human foreskin. Single
cell suspensions were prepared as described previously (Boorsma et al,
1994) and seeded in six well (35 mm) cell culture clusters plates (Costar
Europe, Badhoevedorp, The Netherlands). Keratinocytes were grown in
low calcium (0.1 mM) serum-free medium (keratinocyte-SFM, Gibco
BRL, Breda, The Netherlands) supplemented with epidermal growth
factor, bovine pituitary extract, glutamine (2 mM), penicillin (100 U per
ml), and streptomycin (100 µg per ml), all from Gibco BRL, and used
between passage numbers 3 and 5.
Stimulations, chromatography, and mass analysis Keratinocytes
were stimulated with 2000 U human rIFN-γ (Janssen Biochimica, Beerse,
Belgium) per ml for 6 h. Cell cultures were extensively washed and
incubated in MCDB 153 medium (without phenol red) (Gibco BRL) for
18 h at 37°C. Supernatants were filtered through a 0.22 µm filter and
applied to a 1 ml HiTrap heparin column (Pharmacia, Uppsala, Sweden).
The column was washed with 10 ml 10 mM sodium phosphate, pH 7.3,
10 ml 10 mM sodium phosphate 1 0.35 M NaCl and eluted with 1.5 M
NaCl in sodium phosphate. Obtained material was subsequently desalted and
further separated by reverse phase high-performance liquid chromatography
(HPLC) on a Nucleosil C-18 column (2.1 3 250 mm) using a discontinuous
gradient beginning with 0%–30% acetonitril in 0.05 M HCl in 5 min
followed by 30%–60% acetonitril in 0.05 M HCl over 30 min and
collecting 1 min fractions. Additional purification was obtained by reverse-
phase HPLC on the same column using a more shallow gradient: 0%–21%
in 5 min followed by 21%–36% acetonitrile in 0.05 M HCl over 60 min
and collecting 1 min fractions. Purified material was partially lyophilized
to remove the acids and organic solutions and tested in bioassays on CHO
cells expressing the CXCR3. N-terminal amino acid sequence analysis was
done on an Applied Biosystems model 473 pulse liquid sequencer, using
the sequencer program recommended by the manufacturer (ABI; Foster
City, CA). Mass determination was performed using matrix-assisted laser
desorption-time of flight mass spectrometry (MALDI-TOF/MS) as
described by Jimenez et al (1997).
Expression of CXCR3 and Ca2F measurements The full-length
open reading frame of the CXCR3 receptor, cloned into pcDNA III
(gift from Dr. M. Loetscher) was co transfected into CHO-K1 cells over-
expressing Gα-16 (Stables et al, 1997; gift from Dr. S. Rees, GLAXO,
Stevenhage, U.K.) using lipofectin following the manufacturers’ instructions
(Gibco BRL). Stably transfected cells were selected with G418 (400 µg
per ml).
For Ca21 assays, CHO cells were suspended in phosphate-buffered saline
pH 7.4 containing 1 mM CaCl2 and 0.1% bovine serum albumin. Cells
were then loaded with 1 µM Fura-2 acetoxymethyl ester (Molecular
Probes, Eugene, OR) for 30 min at 37°C in the dark, washed twice, and
diluted to 2 3 106 cells per 2 ml in phosphate-buffered saline/CaCl2.
Fluorescence recordings were made in a continuously stirred cuvette at
37°C in a fluorescence spectrophotometer (Shimadzu, Shimadzu-Benelux,
Hertogenbosch, The Netherlands).
Data were recorded as the relative ratio of fluorescence emitted at
510 nm after sequential excitation at 340 and 380 nm. Each run was
individually calibrated and intracellular calcium was quantitated using
equations described by Grynkiewicz et al (1985). Human recombinant
IP-10, Mig and interleukin (IL)-8 were from Peprotech (Rocky Hill, NJ).
Isolation and culture of human T cells and in vitro chemotaxis
Human peripheral blood mononuclear leukocytes were isolated from buffy
coats of healthy donors obtained from the Dutch Red Cross Central
Laboratory of Blood Transfusion (CLB, Amsterdam, The Netherlands)
after dilution in phosphate-buffered saline and centrifuged on Ficoll-Paque
(Pharmacia, Biotech) at 1000 3 g for 15 min at room temperature.
Peripheral blood mononuclear leukocytes were collected from the interface,
subjected to nylon wool purification to isolate T cells (.95% CD31). T
cells were cultured for 15 d in RPMI 1640 medium with 10% fetal bovine
serum and 400 U human IL-2 per ml in order to induce expression of
CXCR3 (Loetscher et al, 1996; Qin et al, 1998). CXCR3 expression on
these cells was confirmed (.90%) by immunostaining on cytospins with a
monoclonal antibody direct towards human CXCR3 (MAB160; R&D
Systems Europe, Oxon, U.K.). The assay for chemotaxis was performed
in 24 well plates (Costar, Cambridge, MA) carrying Transwell permeable
supports with 5 µm polycarbonate membrane. Cultured T cells were
washed once, and resuspended at 5 3 106 cells per ml in RPMI 1640
containing 0.25% bovine serum albumin. Medium alone or supplemented
with HPLC purified protein was placed in the lower compartment, and
cells were loaded on to the inserts at 0.5 3 106 per 100 µl for each
individual assay. Chambers were incubated for 120 min in a 5% CO2-
humidified incubator at 37°C. After the incubation period, numbers of T
cells migrating to the lower chamber were counted under a microscope
using a hemocytometer. All conditions were tested in triplicate; statistic
evaluation was performed using the Student’s t-test.
Miscellaneous molecular biologic techniques
RNA isolation and cDNA synthesis Monolayers from keratinocytes were
lysed in RNAzol B (after removal of culture supernatants) and processed
according to the manufacturer’s recommendations (CAMPRO, Veenendaal,
The Netherlands). RNA content and purity were measured spectrophoto-
metrically at 260 nm and 280 nm.
Reverse transcription of oligo (d15)T primed total RNA (5 µg) was
performed for 1 h at 42°C in 20 µl using 200 U Superscript II RT (Gibco
BRL) following the manufacturer’s instructions.
PCR PCR on cDNA (500 ng per reaction) were carried out with 1 U
AmpliTaq DNA polymerase (Perkin-Elmer Cetus; Norwalk, CT) using
the recommended dNTP concentrations and buffer supplied by the
manufacturer and were performed in a PTC 200 thermal cycler (MJ
Research; Watertown, MA) using the subsequent cycling protocol: 5 min
at 94°C, followed by 35 cycles each containing of 1 min at 94°C, 1 min
at 60°C, 1 min at 72°C, and a final extension step for 5 min at 72°C.
The obtained products were cloned into pCR Topo (InVitrogen, Leek,
The Netherlands) and sequenced using an Applied Biosystems automated
DNA sequencer (ABI model 373A) in combination with a Perkin-Elmer
dye terminator cycle sequencing kit.
Northern blot analysis For northern blot analysis, RNA samples (10 µg)
were fractionated on 1% agarose gels containing 2.2 M formaldehyde and
transferred to Hybond N (Amersham, Buckinghamshire, U.K.) nylon
membranes. After prehybridization for 2 h in hybridization mix (50%
deionized formamide; 5 3 Denhardt; 50 mM phosphate buffer, pH 6.8;
5 mM ethylenediamine tetraacetic acid; 200 µg per ml herring sperm
DNA; 200 µg per ml yeast RNA; 200 µg per ml tRNA from Escherichia
coli; 0.5% sodium dodecyl sulfate and 0.1% sodium pyrophosphate) mem-
branes were hybridized overnight in the same mix with random primed
[α-32P] labeled IP-9 cDNA (330 bp EcoR1 insert from pCR Topo clone).
The filters were washed four times at 42°C during 60 min under high
stringency conditions (0.1 3 sodium citrate/chloride buffer, 0.1% sodium
dodecyl sulfate) and exposed at –70°C to Kodak X-ray films using a single
intensifying screen. Data were quantitated using a phosphor imaging system
(Molecular Dynamics, Sunnyvale, CA). Yeast 23S and 16S ribosomal RNA
were run along aside as molecular size markers.
In situ hybridization In situ hybridization procedures were carried out as
described previously (Tensen et al, 1998a). For preparation of 35S-labeled
RNA probes, the pCR Topo plasmid DNA harboring the IP-9 cDNA
insert in either orientation was linearized and 35S-labeled sense (control)
and anti-sense RNA probes were obtained by in vitro transcription. To
establish the in vivo localization of IP-9 mRNA, in situ hybridization was
performed on skin biopsies from various skin diseases characterized by the
presence of skin infiltrates with a predominance of activated T cells. These
included skin biopsies from positive patch tests (taken at 48 h) from six
patients allergic for and topically challenged with KathonCG, as well as
skin biopsies from untreated skin lesions of five patients with lichen planus,
seven patients with psoriasis, and five patients with plaque stage mycosis
fungoides. Non-challenged skin from the six patients with allergic contact
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Figure 1. Purification of ligands for CXCR3 from supernatants of
IFN-g stimulated cultured keratinocytes. (A) HPLC chromatogram
obtained after purification of heparin-binding proteins from 3 3 108
keratinocytes. (B) Re-purification of fraction 16 obtained after heparin
column and first step HPLC starting with supernatants of 6 3 108 IFN-γ
stimulated keratinocytes. Bars denote bioactive fractions.
dermatitis and normal skin from five healthy volunteers were included
as controls.
RESULTS
Expression of CXCR3 in CHO cells Stably transfected CHO
cells were screened for expression of a functional CXCR3 receptor
by determining the Ca21 response on application of rIP-10. Of 40
lines tested, six gave a distinct signal, and a single cell line
(CHO-16.6) that produced the most prominent Ca21 response
was used for all subsequent experiments. No signals were found in
untransfected CHO cells (data not shown).
Purification of ligands for the CXCR3 receptor Proteins
present in the supernatant of 3 3 108 keratinocytes stimulated with
IFN-γ were loaded on a heparin HiTrap column. Heparin binding
proteins were eluted and subsequently purified and desalted by
reversed-phase HPLC (Fig 1A). Material purified in this way was
assayed for its ability to induce a calcium flux in the CHO-16.6
cell line expressing the CXCR3 receptor. We detected bioactivity
in fractions 16 and 17 when one of 10 of the obtained fractions
was tested. N-terminal sequence analysis of fraction 17 yielded
two signals corresponding to the N-terminal sequence of IP-10
(VPLSRTVR) and Mig (TPVVRK), whereas N-terminal sequence
analysis of fraction 16 gave two protein sequences:
SGKSFKAGVXPPKKSAQ (as a major component, µ200 pmol)
and FPMFKRGRXLXIG (as a minor component, µ30 pmol). A
computer-assisted database search (BLAST) at NCBI (Altschul et al,
1997), assuming cysteine residues at the positions indicated with
X, revealed 100% homology with human anti-leukoprotease, an
elastase inhibitor (Heinzel et al, 1986) for the first protein whereas
the second protein displayed 100% homology with residues 29–42
of ORF1, a conceptual translation of a cDNA sequence originally
isolated as a differential display PCR product (β-R1) upregulated
by IFN-β or IFN-γ in an astrocytoma cell line (Rani et al, 1996).
Figure 2. Mass spectrum of fraction 26 (Fig 1B) using MALDI-
TOF mass spectrometry. The m/z of 8304 and 4153 correspond to the
protonated (MH1) and doubly protonated (MH2 1) forms of a protein
with a molecular mass of 8303 Da.
Complete separation of both proteins was obtained by repeat-
ing the entire purification procedure, starting with 6 3 108
keratinocytes, and inclusion of an additional rechromatography step
of fraction 16 on reverse phase (Fig 1B). Bioactivity was recovered
from fraction 26. N-terminal amino acid sequence analysis of this
fraction gave a single sequence, FPMFKRGRXLXIGPGVK, thus
unambiguously demonstrating that this protein functionally interacts
with the CXCR3. In general, we isolated 300 pmol of the protein,
which was designated IP-9,1 from 6 3 108 stimulated keratinocytes.
Using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF/MS) the molecular weight of the
isolated protein was determined to be 8303 Da (Fig 2).
Dose–response and cross-desensitization studies Dose–
response experiments were performed in order to determine the
potency of IP-9 (Fig 3A, B) in CXCR3 transfected cell lines. In
the bioassay assay used, IP-9 was µ100 fold more potent (pEC50 5
9.7 6 0.3) than recombinant IP-10 (pEC50 5 7.8 6 0.1; Fig 3B)
and 1000-fold more active that recombinant Mig (pEC50 5
6.4 6 0.5). IP-9 acts as a partial agonist compared with recombinant
IP-10 reaching just about 45% of the maximal effect of IP-10. No
signals were found for IP-9-tested at untransfected CHO cells (data
not shown). Cross-desensitization studies demonstrated a reciprocal
inhibition of IP-9 and IP-10 (Fig 3C), with IP-9 being more
effective in cross-desensitizing the IP-10 response. These latter
effects were also observed for IP-9 and Mig (not shown). A control
CXC chemokine (IL-8) neither had an effect on the transfected
CHO cells nor inhibited the IP-9 response.
Chemotactic activity of IP-9 for activated T cells Having
established that IP-9 is able to activate CXCR3 heterologously
expressed in CHO cells, we tested the chemotactic activity of IP-
9 was towards activated T cells. T cells were cultured for 15 d in
the presence of IL-2, as previous reports demonstrated that this
treatment is necessary for CXCR3 expression by T cells (Loetscher
et al, 1996; Qin et al, 1998). Receptor expression was confirmed
by staining cytospins of cultured T cells with a monoclonal antibody
demonstrating that .90% were positive for CXCR3. As shown in
Table I, 35%–40% of IL-2 activated T lymphocytes, obtained from
several donors, migrated in response to 10 nM of keratinocyte-
derived HPLC purified IP-9.
Molecular cloning of IP-9 encoding cDNA Two oligo nucle-
otide primers were developed based on the βR1 sequence (sense,
59-CAAACATGAGTGTGAAGGGC-39; anti-sense, 59-TTT-
CAGATGCCCTTTTCCAG-39) and used in three independent
PCR reactions in combination with cDNA from IFN-γ stimulated
keratinocytes as a template. A single PCR product of about 330 bp
was obtained, cloned into pCR Topo, and four independent clones
from each PCR reaction were sequenced.
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Figure 3. CXCR3 mediated calcium mobilization. CHO cells stably expressing CXCR3 were loaded with Fura-2 AM and intracellular calcium
levels were measured as described under Materials and Methods. (A) Intracellular calcium flux induced by IP-9, representative for four independent
experiments. Calcium transients peaked immediately after addition of IP-9 (1 nM; arrow) and returned to an elevated level above the baseline. (B) Dose–
response curves of IP-9, IP-10, and Mig. The results shown are from a single experiment and are representative for three independent experiments. (C)
Cross-desensitization. Cells were sequentially treated with IP-9 (1 nM) and IP-10 (10 nM) or vice versa as indicated with filled triangle. No effects were
observed for a control CXC chemokine, IL-8 (100 nM).
The IP-9 encoding cDNA contains an open reading frame
encoding a precursor protein of 94 amino acids (Fig 4), which is
expected to be cleaved at residue 21 according to von Heijne’s
rules governing signal cleavage (von Heijne, 1986). Indeed, our
protein sequencing results demonstrate cleavage at residue 21, as
the sequence of the isolated protein starts with Phe at position 22.
The resulting mature protein of 73 amino acids has highest
homology with IP-10 (31% identity) and Mig (26% identity), two
CXC chemokines previously shown to interact with the CXCR3
(Loetscher et al, 1996). It has a theoretical pI of 9.98 and a molecular
weight (average mass) of 8307 Da (nonreduced) and 8303 Da
assuming two cysteine disulfide bridges. This molecular weight of
8303 Da is in perfect agreement with the data obtained from the
mass spectrometric analysis of the isolated protein. It contains the
characteristic four cysteine residues of which the first N-terminal
two are separated by another residue and is thus a member of the
CXC chemokine family.
Analysis of IP-9 mRNA expression in human cultured
keratinocytes Having established that keratinocytes secrete
IP-9 after induction by IFN-γ, we performed northern blot
analysis to examine further the gene transcription regulation in
keratinocytes. After 6 h treatment of cultured keratinocytes with
IFN-γ (500 U per ml) an enhanced accumulation of IP-9 mRNA
was observed. A major band at 1800 bases and a minor band at
2700 bases were detected (Fig 5A). Neither in unstimulated
keratinocytes, nor after stimulation with tumor necrosis factor-α
(500 U per ml), IP-9 mRNA could be detected by northern blot
analysis. After 6 h treatment of the cells with increasing doses of
IFN-γ (0–2500 U per ml) or treatment with a fixed amount of
IFN-γ (500 U per ml) with increasing time intervals (0, 2, 4, 8,
12, 16 h), enhanced accumulation of IP-9 mRNA was observed
(Fig 5B, C). Thus, IP-9 mRNA expression in keratinocytes is
both concentration dependent and time dependent and thus similar
to IP-10 mRNA expression in cultured human keratinocytes
(Boorsma et al, 1998).
Analysis of IP-9 mRNA expression in inflammatory skin
disorders using RNA in situ hybridization (RISH) To
identify and localize IP-9 mRNA expression in skin inflammatory
disorders, skin biopsies from selected benign and malignant inflam-
matory dermatoses characterized by the presence of activated T
cell infiltrates were studied by RISH. IP-9 mRNA expression was
almost exclusively expressed by basal layer keratinocytes in five of
six allergic patch test reactions (e.g., in Fig 6A, B), five of five
lichen planus lesions, four of five epidermotropic mycosis fungoides
but only in one of seven untreated psoriatic lesions. In most cases
IP-9 mRNA had a focal rather than a uniform distribution pattern
and was particularly found in areas showing epidermal infiltration
by activated T cells. In normal skin (n 5 5) and unchallenged skin
from allergic patients, IP-9 mRNA could not be detected. In
Table I. Migration of IL-2 activated T cells towards HPLC
purified native IP-9 and recombinant IP-10a
Lower chamber % migrationb
Donor A Donor B Donor C
Medium alone (control) 7.6 6 4.0 10.4 6 1.1 14.7 6 1.7
Medium 1 10 nM IP-9 31.6 6 12.4c 38.4 6 10.7d 44.0 6 9.1e
Medium 1 10 nM IP-10 10.2 6 2.0 12.0 6 4.0 16.4 6 2.1
Medium 1 100 nM IP-10 26.4 6 9.1c 34.9 6 8.7d 48.0 6 7.1e
aEach value represents the mean 6 SD. The data are representative for one of
two experiments (with different donors) performed.
bMigration was calculated as percentage from input cells migrating to lower
chamber.
cSignificant different from control at p , 0.05.
dSignificant different from control at p , 0.02.
eSignificant different from control at p , 0.01.
control experiments (cytospin preparations of IFN-γ stimulated
cultured keratinocytes) cytoplasmic IP-9 mRNA accumulation was
evident (Fig 6D), whereas in unstimulated keratinocytes IP-9
mRNA was not found (Fig 6E). Sense probes were negative in
all cases (Fig 6C, F).
DISCUSSION
Chemokine action is mediated through activation of membrane-
bound G-protein-coupled seven transmembrane receptors resulting
in uncoupling of the G-protein, which in turn leads to the
generation of an intracellular second messenger response such as
Ca21 mobilization. A cDNA encoding the chemokine receptor
CXCR3 was stably expressed in CHO cells and these cells were
challenged with partially purified proteins obtained from stimulated
keratinocytes, and subsequently effects on Ca21 mobilization were
monitored. By this approach we were not only able to purify and
identify biologically active Mig and IP-10 as proteins secreted by
IFN-γ stimulated keratinocytes, but in addition we identified a
novel highly potent ligand for the CXCR3 receptor, designated
IP-9. Approximately equal amounts of IP-9 and Mig were isolated,
whereas 40 times more IP-10 was recovered from IFN-γ stimulated
keratinocytes. The molecular weight of IP-9 as determined by
MALDI-TOF/MS (8303 Da) is identical to the weight predicted
on the basis of the deduced amino acid sequence data (8303 Da),
indicating that, at least in keratinocytes, there are no post-transla-
tional modifications.
IP-9 is µ100-fold more potent (pEC50 5 9.7 6 0.3) in
activation of the CXCR3 expressed in CHO cells compared with
recombinant IP-10 (pEC50 5 7.8 6 0.1) and 1000-fold more
active than recombinant Mig (pEC50 5 6.4 6 0.5). Furthermore,
IP-9 is much more active in cross-desensitization of chemokine-
induced Ca21 mobilization in transfected CHO cells: 1 nM IP-9
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Figure 4. IP-9 cDNA and deduced protein sequence. Numbers on the right denote nucleotides positions in IP-9 starting with 1 as the first
nucleotide in the sense PCR primer. The cDNA sequence of IP-9 is available under accession no. Y15220 in the EMBL/GenBank database The deduced
amino acid sequence is indicated in single letter codes above the cDNA sequence, with the stop codon indicated by an asterisk. Cysteines in the mature
protein are indicated with a dot, arrow indicates signal peptide cleavage site.
Figure 5. Northern analysis of IP-9
mRNA expression in cultured kerat-
inocytes. (A) Cells were cultured for 6 h in
the presence of medium (1), IFN-γ (500 U
per ml; 2) or tumor necrosis factor-α
(Genzyme, Cambridge, MA; 500 U per ml;
3). Total RNA was isolated and analyzed by
northern blotting for IP-9 mRNA
expression. Molecular size markers are
indicated on the left. (B) and (C) Time- and
concentration-dependent accumulation of
IP-9 mRNA in keratinocytes. Keratinocytes
were stimulated with a fixed amount of
IFN-γ (500 U per ml) for 0, 2, 4, 6, 8, or
12 h (B). Keratinocytes were stimulated with
different doses of IFN-γ (0, 20, 100, 500, or
2500 U per ml) for 6 h (C). IP-9 mRNA
expression was analyzed by northern blotting;
β-actin was used as reference gene to control
loading of the lanes. IP-9 mRNA data were
normalized to β-actin and expressed as
percentage of maximal IP-9 mRNA
expression. Data are representative for at least
three independent experiments.
inhibits IP-10 (10 nM) or Mig (100 nM) responses, whereas 1 nM
IP-9 still generates a response after previous activation by 10 nM
IP-10 or 100 nM Mig.
IP-9 as isolated by HPLC from stimulated keratinocytes, was
also tested for its chemotactic activity towards activated T cells. In
chemotactic assays, about 35%–40% of the input T cells were
attracted by 10 nM IP-9, whereas 10 nM IP-10 (a concentration
sufficient for CXCR3 activation in CHO cells; Fig 3) was
ineffective, which again demonstrated the greater potency of IP-9
compared with IP-10.
A GenBank query using the obtained N-terminal protein
sequence of purified IP-9, revealed that the IP-9 mRNA was
seemingly identical to an mRNA sequence originally isolated as a
differential display PCR product (β-R1) upregulated by IFN-β or
IFN-γ in an astrocytoma cell line (Rani et al, 1996). As the cDNA
sequence in this database entry was incomplete and contained
several sequence ambiguities, we then applied a PCR-based cloning
strategy to obtain a correct cDNA sequence encoding the complete
IP-9 precursor protein. From the obtained cDNA and deduced
protein sequence it became clear that IP-9 is a CXC-chemokine
related in sequence to Mig and IP-10, a feature not recognized by
Rani et al (1996) for β-R1. After completion of the DNA sequence
analyses and submission of the sequence to the EMBL Nucleotide
Sequence Database, a database entry was released to GenBank
(designated H174; accession no. AF002985; Jacobs et al, 1997)
confirming our cDNA sequencing results. Very recently, when this
manuscript was under review, a cDNA sequence (identical to IP-
9 and H174 in its coding region) was published once again
(accession no. AF030514) and designated I-TAC (Cole et al, 1998).
A synthetic peptide based on the I-TAC cDNA sequence was able
to activate CXCR3 heterologously expressed in a mouse pre-B
cell line. In addition, these authors also demonstrated that the
synthetic I-TAC is a chemoattractant for IL-2 stimulated T cells.
The determined and calculated molecular mass of the folded
synthetic I-TAC used for these studies (8042.6 Da); however, is
Figure 6. IP-9 mRNA expression in allergic contact dermatitis skin
biopsies and cultured keratinocytes using in situ hybridization.
In situ hybridization with 35S-UTP-labeled IP-9 anti-sense RNA probe
(A, B, D, E) and sense RNA probe (B, F) followed by emulsion
autoradiography was performed on cryostat sections or cytospin preparations
as described in Materials and Methods. (A–C) Epidermal IP-9 mRNA
expression in allergic contact dermatitis. Silver grains representing sites of
IP-9 mRNA transcripts in the epidermis appear black in bright field (A)
and white in dark-field (B) illumination of the same section. (C) Absence
of silver grains using a sense probe on a serial section of the same biopsy
demonstrate the specificity of the in situ hybridization procedure (dark-
field illumination). (D) Cytoplasmic IP-9 mRNA expression in stimulated
(500 U per ml IFN-γ for 6 h) cultured keratinocytes. (E) No IP-9 mRNA
in unstimulated keratinocytes. (F) Absence of silver grains using a sense
probe on a cytospin of stimulated keratinocytes (as in D) again showing
the specificity of the in situ hybridization procedure. (D–F) Bright-field
illumination. Scale bar: 40 µm.
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not in accordance with the calculated and determined mass of folded
IP-9 (8303 Da) as isolated by us from stimulated keratinocytes.
Interestingly, this mass difference corresponds exactly with the mass
of the last two amino acids of IP-9 (Asn-Phe), suggesting that all
experiments in the aforementioned study were carried out with a
incorrectly synthesized, C-terminal truncated peptide. As we
isolated, characterized, and tested IP-9 as a natural intact protein,
we prefer to use the terminology IP-9 for the chemokine encoded
by IP-9, β-R1, H174, or I-TAC mRNA.
We used the cloned cDNA as a probe to study gene-transcription
regulation in cultured human keratinocytes. With northern blot
analysis, IP-9 mRNA could only be demonstrated in IFN-γ and
not in unstimulated keratinocytes. The expression of IP-9 mRNA
in keratinocytes was shown to be concentration and time dependent,
and is thus similar to IP-10 mRNA expression in cultured human
keratinocytes (Boorsma et al, 1998).
Using in situ hybridization, it was confirmed that cultured
keratinocytes strongly express IP-9 mRNA upon stimulation with
IFN-γ, whereas unstimulated keratinocytes are completely negative
(Fig 6). To investigate a potential role for IP-9 in the pathogenesis
of inflammatory skin disorders, skin biopsies of various skin diseases,
characterized by the presence of skin infiltrates with a predominance
of activated T cells, were studied for IP-9 mRNA expression by
RISH. In most cases IP-9 mRNA had a focal rather than a uniform
distribution pattern and was particularly found in areas showing
epidermal infiltration by activated T cells. Comparing IP-9 mRNA
expression with IP-10 and Mig mRNA expression on serial sections
of epidermotropic mycosis fungoides biopsies (Tensen et al, 1998a),
showed a strong correlation between IP-9 and IP-10 expression.
IP-10 signals, however, were often much stronger and localized
both in the epidermis and dermis. In contrast, Mig mRNA was
preferentially expressed in the dermal infiltrates. Consistently, more
recent studies on skin biopsies from allergic contact reactions
showed similar differences in the distribution patterns of IP-9, IP-
10, and Mig.2–4
The consistent topographical difference in expression patterns
(IP-9 epidermal, IP-10 epidermal and dermal, Mig mainly dermal)
is reminiscent to the results described by Gillitzer et al (1996)
studying chemokine mRNA expression in relation to migration of
neutrophils in psoriatic lesions. These authors observed differential
expression of Gro-α (expression was found in dermis and epidermis)
and IL-8 (detected only in the epidermis), leading to the hypothesis
that Gro-α is a primary chemoattractant for neutrophil diapedesis,
whereas further migration of neutrophils towards the epidermis is
a result of the cooperative action of both Gro-α and IL-8. In
analogy, expression of IP-9, IP-10, and Mig in different skin
compartments could be involved in the control of migration of a
CXCR3 bearing T lymphocyte. In this view, dermal Mig enhances/
induces T lymphocyte extravasation and access to the cutaneous
milieu. Next, higher amounts of (epi)dermal IP-10 can stimulate
the CXCR3 and would further lead lymphocytes along a gradient
into the direction of the epidermis. Finally, IP-9 may attract
lymphocytes across the dermal–epidermal barrier.
Aside from the identification of IP-9 as a keratinocyte-derived
chemokine potentially involved in the recruitment of activated
T cells to the skin, its high affinity for CXCR3 has an additional
important implication. Recently, Mig and IP-10 were reported to
exhibit anti-tumor effects in distinct preclinical models not only
by attracting tumor infiltrating T cells, but also as potent inhibitors
of neovascularization (Luster and Leder, 1993; Arenberg et al, 1996;
Sgadari et al, 1996, 1997). Consequently, the identification of IP-
2Flier et al, submitted
3Flier J, Boorsma DM, van Beek PJ, et al: Differential expression of
IFN-γ induced CXC chemokines IP-10 and MIG in inflammatory skin
diseases. J Invest Dermatol 110:658, 1998 (abstr.)
4Flier J, van der Stoop PM, van Beek PJ, et al: IP-10 mRNA is expressed
in allergic but not in irritant contact dermatitis. J Invest Dermatol 109:451,
1997 (abstr.)
9 as a chemokine closely related to and more potent than IP-10
and Mig towards CXCR3 warrants further studies determining the
potential anti-tumor properties of IP-9. Finally, we propose that
the utilized strategy described in this manuscript might also be
applicable for the identification of novel endogenous keratinocyte-
derived ligands for already classified chemokine receptors or might
be used to identify hitherto unknown ligands for ‘‘orphan’’ chemok-
ine receptors.
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